Natural Products from Garcinia brasiliensis as Leishmania Protease Inhibitors

다국어 초록 (Multilingual Abstract)

The infections by protozoans of the genus Leishmania are a major worldwide health problem, with high endemicity in developing countries. The drugs of choice for the treatment of leishmaniasis are the pentavalent antimonials, which cause renal and cardiac toxicity. As part of a search for new drugs against leishmaniasis, we evaluated the in vitro Leishmania protease inhibition activity of extracts (hexanic, ethyl-acetate, and ethanolic) and fukugetin, a bioflavonoid purified from the ethyl-acetate extract of the pericarp of the fruit of Garcinia brasiliensis, a tree native to Brazilian forests. The isolated compound was characterized by using spectral analyses with nuclear magnetic resonance, mass spectroscopy, ultraviolet, and infrared techniques. The ethyl-acetate extract and the compound fukugetin showed significant activity as inhibitors of Leishmania's proteases, with mean (±SD) IC50 (50% inhibition concentration of protease activity) values of 15.0±1.3 μg/mL and 3.2±0.5 μM/mL, respectively, characterizing a bioguided assay. In addition, this isolated compound showed no activity against promastigote and amastigote forms of L. (L.) amazonensis and mammalian cells. These results suggest that fukugetin is a potent protease inhibitor of L. (L.) amazonensis and does not cause toxicity in mammalian or Leishmania cells in vitro. This study provides new perspectives on the development of novel drugs that have leishmanicidal activity obtained from natural products and that target the parasite's proteases.

참고문헌 (Reference)

1 Fumiko ABE, "Trypanocidal constituents in plants 3.1. Leaves of Garcinia intermedia and heartwood of Calophyllum brasiliense" 27 : 141-143, 2004

2 Gustafson KR, "The guttferones, HIVinhibitory benzophenones from symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusia rosea" 48 : 10093-10102, 1992

3 McKerrow JH, "The cysteine protease of Trypanosoma cruzi as a model for antiparasitic drug design" 11 : 279-282, 1995

4 Konoshima M, "The constitution of flavonoids from hook.f" 10 : 121-124, 1969

5 Melo RL, "Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides" 293 : 71-77, 2001

6 Torres-Santos EC, "Selective effect of 20,60-di-hydroxy-40-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis" 43 : 1234-1241, 1999

7 Mottram JC, "Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions" 1 : 445-460, 1998

8 Mossman T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays" 65 : 55-63, 1983

9 Hide G, "Proteases in trypanosomatids: biology and control. In: Trypanosomiasis and leishmaniasis" CAB International 176-197, 1997

10 Chan-Bacab MJ, "Plant natural products with leishmanicidal activity" 18 : 674-688, 2001

11 Marcucci MC, "Phenolic compounds from Brazilian propolis with pharmacological activities" 74 : 105-112, 2001

12 Robertson CD, "Parasite cysteine proteinases" 6 : 99-118, 1996

13 Martins FT, "Natural polyprenylated benzophenones inhibiting cysteine and serine proteases" 44 : 1230-1239, 2009

14 Monache GD, "Minor xanthones from Rheedia gardneriana" 23 : 1757-1759, 1984

15 Pereira IO, "Leishmanicidal activity of benzophenones and extracts from Garcinia brasiliensis Mart. Fruits" 17 : 339-345, 2010

16 World Health Organization, "Leishmaniasis: the disease and its impact"

17 World Health Organization, "Leishmaniasis: geographical distribution"

18 Croft SL, "Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs" 19 : 502-508, 2003

19 Herwaldt BL, "Leishmaniasis" 354 : 1191-1199, 1999

20 Selzer PM, "Leishmania major molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors" 87 : 212-221, 1997

21 Tripathi S, "Landrace/gender based differences in phenol and thiocyanate contents and biological activity in Piper betle L" 91 : 746-749, 2006

22 Sauvain M, "Isolation of leishmanicidal triterpenes and lignans from Amazonian liana Doliocorpus dentatus (Dilleniaceae)" 10 : 1-4, 1996

23 Kayser O, "In vitro leishmanicidal activity of monomeric and dimeric naphtoquinones" 76 : 131-138, 2000

24 Rosenthal PJ, "Identification of three stage-specific proteinases from Plasmodium palcifarum" 166 : 816-821, 1999

25 Desai PV, "Identification of novel parasitic cysteine protease inhibitors using virtual screening" 16 : 6609-6615, 2004

26 Khaw M, "Human antiprotozoal therapy: past, present and future" 8 : 427-439, 1995

27 Edzard E, "Harmless herbs? A review of the recent literarure" 104 : 170-178, 1998

28 Martinez E, "Estudio quimico y actividad biologica de tres especies de la familia rutaceae" 25 : 15-27, 1996

29 Sadij M, "Cysteine proteases of parasitic organisms" 120 : 1-21, 2002

30 Mottram JC, "Cysteine peptidases as virulence factors of Leishmania" 7 : 375-381, 2004

31 Derogis PBMC, "Complete assignment of the 1H and 13C NMR spectra of garciniaphenone and keto-enol equilibrium statements for prenylated benzophenones" 46 : 278-282, 2008

32 Croft SL, "Chemotherapy of trypanosomiases and leishmaniasis" 21 : 508-512, 2005

33 Botta B, "Chemical investigation of the genus Rheedia. V. Bi-flavonoids and xanthochymol" 47 : 1053-1064, 1984

34 Barrett AJ, "Cathepsin B, cathepsin H and cathepsin L" 80 : 535-561, 1981

35 Araujo CAC, "Antileishmanial activity of compounds extracted and characterized from Centrolobium sclerophyllum" 49 : 751-754, 1998

36 Delorenzi JC, "Antileishmanial activity of an indole alkaloid from Peschiera australis" 45 : 1349-1354, 2001

37 Ferreira ICP, "Antileishmanial acitivity of alkaloidal extract from Aspidosperma ramiflorum" 99 : 1-3, 2004

38 Urzua A, "Antibacterial properties of 3 H-Spiro[1-benzofuran-2,10-cyclohexane] derivatives from Heliotropium filifolium" 13 : 2385-2393, 2008